ITGAX and acute myeloid leukemia: As given in Fig. 5a we found higher fold-changes (> 1.5) of CD11c, CD44, CD133, and lower fold-changes (> 1) of CD49e and MCSP positive serum-derived EVs in AML than in healthy samples.